‘genomics’ Category

What Has Data Done For You Lately?

| February 06, 2013

Current and past Rock Health entrepreneurs presenting at the Burrill Digital Health Meeting on February 5th. In order from top left: Nick Crocker (Sessions), Jason Oberfest (Mango Health), Robert Goldberg (Neumitra), Borna Safabakhsh (Agile Diagnosis), Jason Langheier (Zipongo), and Sean Duffy (Omada Health).

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Will all this new health data we’re amassing really, on its own, induce behavior change? The consensus answer is a pretty straightforward no.

Any casual observer of health trends can tell you that the basic data physicians have been sharing in every primary care visit for decades, such as heart rate, blood pressure, blood glucose, and cholesterol levels, have not been enough to motivate the average patient to change her lifestyle. But what about the more personalized, granular information and methods presently growing and democratizing, such as genomics and the so-called Quantified Self?

(more…)

Syapse Aims To Make Personalized Medicine A Clinical Reality

| January 23, 2013

Yesterday Palo Alto-based startup Syapse announced $3 million Series A funding led by The Social+Capital Partnership. In conjunction with the investment, Social+Capital founder (and former Facebook executive) Chamath Palihapitiya joins Syapse’s Board of Directors.

Currently, medical diagnosis and treatment is largely one-size-fits-all. In the burgeoning field of genetic testing that could better individualize care, lab results and their implications are incredibly complex, requiring specialized genetic counselors to act as intermediaries who review and interpret genetics lab results and, in turn, educate patients and doctors who might otherwise misinterpret the results. (more…)

Personalization: Not just for pharma

| May 14, 2012


 
 

 

 

 

 

 

 

 

 

 
 
Personalized medicine frequently refers to the incorporation of genomic and molecular profiling data into pharmaceutical treatment of diseases such as cancer. But personalization is a market trend that is applicable beyond medical treatment of disease: it is a model that can be applied to a broad range of consumer health products and services, and companies–from Fortune 500s to startups–are taking notice.  Rock Health looks at this trend more closely in its most recent Rock Report, Taking Health Personally: Personalization as a Consumer Health Trend.

(more…)

Roundup of the Future of Genomic Medicine Conference

| March 07, 2012

Over 450 people registered for last week’s Future of Genomic Medicine V Conference, held on March 1st and 2nd and hosted by the Scripps Translational Science Institute in San Diego, California. Held at the picturesque Scripps Seaside Forum, the meeting addressed issues relevant to whole genome and exome sequencing, pharmacogenomics, and idiopathic diseases (diseases that develop without an apparent or known cause).
(more…)